Orthostatic Symptoms and Reductions in Cerebral Blood Flow in Long-Haul COVID-19 Patients: Similarities with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 9425208 Publication Model: Electronic Cited Medium: Internet ISSN: 1648-9144 (Electronic) Linking ISSN: 1010660X NLM ISO Abbreviation: Medicina (Kaunas) Subsets: MEDLINE

Publication: 2018- : Basel, Switzerland : MDPI
Original Publication: Kaunas : Lietuvos gydytojų sąjunga

COVID-19*/complications ; Fatigue Syndrome, Chronic*; Blood Pressure ; Cerebrovascular Circulation ; Humans ; SARS-CoV-2 ; Post-Acute COVID-19 Syndrome

Background and Objectives : Symptoms and hemodynamic findings during orthostatic stress have been reported in both long-haul COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), but little work has directly compared patients from these two groups. To investigate the overlap in these clinical phenotypes, we compared orthostatic symptoms in daily life and during head-up tilt, heart rate and blood pressure responses to tilt, and reductions in cerebral blood flow in response to orthostatic stress in long-haul COVID-19 patients, ME/CFS controls, and healthy controls. Materials and Methods : We compared 10 consecutive long-haul COVID-19 cases with 20 age- and gender-matched ME/CFS controls with postural tachycardia syndrome (POTS) during head-up tilt, 20 age- and gender-matched ME/CFS controls with a normal heart rate and blood pressure response to head-up tilt, and 10 age- and gender-matched healthy controls. Identical symptom questionnaires and tilt test procedures were used for all groups, including measurement of cerebral blood flow and cardiac index during the orthostatic stress. Results : There were no significant differences in ME/CFS symptom prevalence between the long-haul COVID-19 patients and the ME/CFS patients. All long-haul COVID-19 patients developed POTS during tilt. Cerebral blood flow and cardiac index were more significantly reduced in the three patient groups compared with the healthy controls. Cardiac index reduction was not different between the three patient groups. The cerebral blood flow reduction was larger in the long-haul COVID-19 patients compared with the ME/CFS patients with a normal heart rate and blood pressure response. Conclusions : The symptoms of long-haul COVID-19 are similar to those of ME/CFS patients, as is the response to tilt testing. Cerebral blood flow and cardiac index reductions during tilt were more severely impaired than in many patients with ME/CFS. The finding of early-onset orthostatic intolerance symptoms, and the high pre-illness physical activity level of the long-haul COVID-19 patients, makes it unlikely that POTS in this group is due to deconditioning. These data suggest that similar to SARS-CoV-1, SARS-CoV-2 infection acts as a trigger for the development of ME/CFS.

J Am Soc Echocardiogr. 1995 Sep-Oct;8(5 Pt 1):647-53. (PMID: 9417207)
Heart Rhythm. 2015 Jun;12(6):e41-63. (PMID: 25980576)
J Neurol. 2020 Aug;267(8):2179-2184. (PMID: 32458193)
J Appl Physiol (1985). 2014 Nov 15;117(10):1157-64. (PMID: 25277740)
Clin Auton Res. 2002 Aug;12(4):273-80. (PMID: 12357281)
J Intern Med. 2011 Oct;270(4):327-38. (PMID: 21777306)
JAMA. 1995 Sep 27;274(12):961-7. (PMID: 7674527)
J Neurol Sci. 2011 Feb 15;301(1-2):9-11. (PMID: 21167506)
BMC Neurol. 2011 Mar 24;11:37. (PMID: 21435231)
J Transl Med. 2020 Sep 1;18(1):335. (PMID: 32873297)
EClinicalMedicine. 2021 Aug;38:101019. (PMID: 34308300)
Front Pediatr. 2019 Feb 15;7:26. (PMID: 30828572)
Semin Arthritis Rheum. 2000 Oct;30(2):79-86. (PMID: 11071579)
Clin Neurophysiol Pract. 2020 Feb 08;5:50-58. (PMID: 32140630)
Minn Med. 1999 Nov;82(11):52-6. (PMID: 10589213)
Arch Intern Med. 2009 Dec 14;169(22):2142-7. (PMID: 20008700)
J Transl Med. 2021 May 4;19(1):193. (PMID: 33947430)
Brain Behav Immun. 2019 Jan;75:94-100. (PMID: 30261303)
Magn Reson Imaging. 2016 May;34(4):603-8. (PMID: 26708036)
Europace. 2006 Mar;8(3):199-203. (PMID: 16627440)
Brain Imaging Behav. 2019 Jun;13(3):789-797. (PMID: 29855991)
Auton Neurosci. 2011 Apr 26;161(1-2):46-8. (PMID: 21393070)
Clin Auton Res. 2020 Oct;30(5):449-451. (PMID: 32880754)
Bull IACFS ME. 2009;17(3):88-106. (PMID: 21243091)
Brain Imaging Behav. 2020 Apr;14(2):562-572. (PMID: 30617782)
BMC Med Res Methodol. 2018 Jan 17;18(1):11. (PMID: 29343224)
eNeurologicalSci. 2020 Dec;21:100276. (PMID: 32984564)
J Nucl Med. 2014 Jun;55(6):945-50. (PMID: 24665088)
Ann Intern Med. 1994 Dec 15;121(12):953-9. (PMID: 7978722)
Neurosci Lett. 2021 Jan 18;742:135528. (PMID: 33248159)
J Am Coll Cardiol. 2010 Jun 22;55(25):2858-68. (PMID: 20579544)
Clin Auton Res. 2021 Jun;31(3):385-394. (PMID: 33860871)
Ther Adv Infect Dis. 2021 Apr 20;8:20499361211009385. (PMID: 33959278)
J Physiol. 2011 Jun 1;589(Pt 11):2847-56. (PMID: 21486813)
Neurology. 2012 Oct 2;79(14):1435-9. (PMID: 22993288)
Curr Rheumatol Rep. 2016 May;18(5):24. (PMID: 27032787)
JAMA. 2020 Aug 11;324(6):603-605. (PMID: 32644129)
Heart. 2006 Dec;92(12):1795-800. (PMID: 16803940)
Immunol Res. 2021 Apr;69(2):205-211. (PMID: 33786700)
Arch Phys Med Rehabil. 1999 Sep;80(9):1090-4. (PMID: 10489014)
Am J Physiol Heart Circ Physiol. 2009 Aug;297(2):H664-73. (PMID: 19502561)
J Neurol. 2021 Dec;268(12):4448-4478. (PMID: 34009454)
Psychol Med. 2010 Aug;40(8):1253-67. (PMID: 20047703)
Acta Neurol Scand. 2016 Aug;134(2):108-15. (PMID: 26427910)
J Psychosom Res. 2002 Sep;53(3):749-53. (PMID: 12217448)
J Mol Neurosci. 2021 Nov;71(11):2192-2209. (PMID: 33464535)
J Am Coll Cardiol. 2017 Aug 1;70(5):620-663. (PMID: 28286222)
J Innov Card Rhythm Manag. 2020 Nov 15;11(11):4302-4304. (PMID: 33262898)
Clin Neurophysiol Pract. 2018 Mar 23;3:91-95. (PMID: 30215015)
Neurol Sci. 2020 Oct;41(10):2657-2669. (PMID: 32725449)
J Neuroimaging. 2003 Jan;13(1):57-67. (PMID: 12593133)
Clin Neurol Neurosurg. 2020 Jul;194:105921. (PMID: 32422545)
Health Qual Life Outcomes. 2003 Oct 03;1:49. (PMID: 14613572)
Ann Clin Transl Neurol. 2020 Oct;7(10):2057-2071. (PMID: 32853453)
J Cardiovasc Electrophysiol. 2009 Mar;20(3):352-8. (PMID: 19207771)
Front Med (Lausanne). 2021 Apr 29;8:668944. (PMID: 33996867)
Ann Rheum Dis. 1973 Sep;32(5):413-8. (PMID: 4751776)
J Pediatr. 2002 Apr;140(4):412-7. (PMID: 12006954)
J Appl Physiol (1985). 2007 Oct;103(4):1128-35. (PMID: 17626834)
JACC Case Rep. 2021 Apr;3(4):573-580. (PMID: 33723532)
Clin Med (Lond). 2021 Jan;21(1):e63-e67. (PMID: 33243837)
Pediatrics. 2009 Jul;124(1):189-93. (PMID: 19564299)
Clin Sci (Lond). 2012 Mar;122(5):227-38. (PMID: 21919887)
J Am Heart Assoc. 2020 Dec 15;9(24):e017861. (PMID: 33280488)
BMJ. 2006 Sep 16;333(7568):575. (PMID: 16950834)

Keywords: cerebral blood flow (CBF); chronic fatigue syndrome (CFS); long-haul COVID-19; myalgic encephalomyelitis (ME); orthostatic intolerance; postural orthostatic tachycardia syndrome (POTS); tilt testing

Date Created: 20220121 Date Completed: 20220124 Latest Revision: 20221207

20240829

PMC8778312

10.3390/medicina58010028

35056336